M. Delcroix (Leuven, Belgium), A. Fijalkowska (Warsaw, Poland)
Sticker reminders improve VTE prophylaxis appropriatness in hospitalized patients
B. Sharif-Kashani, S. Raeissi Roodashti, B. Bikdeli, P. Shahabi, N. Behzadnia, L. Saliminejad, M. Samiei-Nejad, F. Nasiri, M. Khayyami, B. Foroutan, S. Pozhan, T. Javan-Amoli, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
|   |
Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH
V. Grinstead, S. Murphy, J. Mukherjee (Warwick, United Kingdom)
| |
The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE
S. Guinard, E. Noel-Savina, C. Tromeur, G. Quere, C. Leroyer, D. Mottier, F. Couturaud (Brest, France)
| |
The relevant research of pulmonary thromboembolism and Protein C gene polymorphism
J. Liu, Y. Zhang (Shanghai, China)
| |
Clinical Gestalt and the prognosis of pulmonary embolism
C. Zamarro, V. Gómez, M. Soto, D. Kopecna, D. Sánchez, G. de Luna, A. Sam, C. Wagner, A. Sueiro, D. Jiménez (Madrid, Spain)
| |
Clinical probability and d-dimer utility in the context of suspected pulmonary embolism: The safe approach
H. Ramadan, H. Shere, B. Sales, A. Grove, A. Roberts (Winchester, United Kingdom)
| |
Prognostic value of the Geneva prediction rules in patients without pulmonary embolism
L. Bertoletti, G. Le Gal, H. Bounameaux, A. Perrier, M. Righini (Switzerland; Saint-Etienne, Brest, France)
| |
The safety and effectiveness of outpatient management of pulmonary embolism
C. Lee, S. Packham (Swansea, United Kingdom)
| |
Outpatient investigation and treatment of suspected acute pulmonary embolism in patients who require diagnostic imaging
J. Ramsay, D. Wozniak (Luton, United Kingdom)
| |
Diagnostic value of incidental findings in patients without pulmonary embolism on CT pulmonary angiogram and a normal chest x-ray
K. Sharma, I. Saleem, J. Lyons, O. Carney, J. J. Gilmartin (Galway, Ireland)
| |
Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein
M. Wynants, R. Quarck, E. Alfaro-Moreno, M. R. Sepulveda, F. Wuytack, A. Ronisz, D. Van Raemdonck, B. Meyns, M. Delcroix (Belgium; Mexico City, Mexico)
| |
Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
R. Quarck, E. Verbeken, B. Meyns, M. Delcroix (Belgium)
| |
Dose-related effect of statins on the occurrence of venous thromboembolism
D. Khemasuwan, S. Gupta, Y. K. Chae, A. Carpio, J. H. Yun, S. Neagu, A. Lucca, M. E. Valsecchi, J. Mora (Philadelphia, United States Of America)
| |
Diastolic pulmonary artery pressure (dPAP) at three months post pulmonary endarterectomy (PEA) as a new prognostic factor
A. Kacprzak, D. Jenkins, K. Sheares, C. Treacy, R. Mackenzie Ross, J. Pepke-Zaba (Papworth Everard, United Kingdom)
| |
5 year survival of patients with distal chronic thromoembolic pulmonary hypertension; comparison of treated patients with distal disease and residual disease post pulmonary endartectomy
C. Treacy, K. Page, R. Mackenzie Ross, G. Hagan, J. Pepke-Zaba, D. Jenkins (Cambridge, United Kingdom)
| |
Comparison of subcutaneous (sc) treprostinil use for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in 2 Belgian centers
E. Vandevelde, M. T. Gautier, C. Vanaken, I. Lankriet, W. Wuyts, R. Naeije, J. L. Vachiery, M. Delcroix (Anderlecht, Belgium)
| |
Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice
J. Wan, L. Lu, R. Miao, J. Liu, J. Wang, C. Wang (Beijing, China)
| |
Reinfusion of spleen cells is correcting altered thrombus organisation after splenectomy
M. K. Renner, B. Redwan, M. P. Winter, A. Panzenboeck, J. Jakowitsch, R. Sadushi-Kolici, D. Bonderman, I. Lang (Austria)
| |